{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:20:23Z","timestamp":1781677223373,"version":"3.54.5"},"reference-count":19,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":210,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Clinical Practice"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p><jats:italic>Aim<\/jats:italic>. The aim of the study was to compare the effectiveness of beta\u2010blockers with other antihypertensive classes in reducing all\u2010cause mortality, cardiovascular\u2010related mortality and the risk of cerebrocardiovascular events. <jats:italic>Methods<\/jats:italic>. This noninterventional study was conducted within the UK Clinical Practice Research Datalink. Hypertensive patients who initiated antihypertensive monotherapy were allocated to one of five cohorts: beta\u2010blockers; angiotensin\u2010converting enzyme inhibitors (ACEi); angiotensin II receptor blockers (ARB); calcium channel blockers (CCB); and diuretics. Differences in outcomes were assessed using Cox proportional hazard models with competing risks. <jats:italic>Results<\/jats:italic>. A total of 44,404 patients were prescribed beta\u2010blockers (75% atenolol), 132,545 ACEi, 12,018 ARB, 91,731 CCB, and 106,547 diuretics. At baseline, patients in the beta\u2010blocker cohort presented more frequently with angina, arrhythmia, and atrial fibrillation. The risk of all\u2010cause mortality was lower for those treated with ACEi, ARB, and CCB, and no difference was observed compared with diuretics (adjusted hazard ratio versus beta\u2010blockers (98.75% CI), for ACEi 0.71 (0.61, 0.83), ARB 0.67 (0.51, 0.88), CCB 0.76 (0.66, 0.88), diuretics 1.06 (0.93, 1.22)). No differences were seen in the risk of cardiovascular mortality for patients treated with beta\u2010blockers, ARB, CCB, and diuretics, while a lower risk in patients treated with ACEi was observed (ACEi 0.63 (0.43, 0.91), ARB 0.64 (0.32, 1.28), CCB 0.71 (0.49, 1.03), diuretics 0.97 (0.69, 1.37)). <jats:italic>Conclusions<\/jats:italic>. These data add to the limited pool of evidence from real\u2010world studies exploring the effectiveness of beta\u2010blockers versus other antihypertensive classes. Discrepancies to previously published studies might be partly explained by differences in the selected populations and in the follow\u2010up time.<\/jats:p>","DOI":"10.1155\/2022\/6124559","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T14:50:09Z","timestamp":1659192609000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Real\u2010World Effectiveness of Beta\u2010Blockers versus Other Antihypertensives in Reducing All\u2010Cause Mortality and Cardiovascular Events"],"prefix":"10.1155","volume":"2022","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0254-5560","authenticated-orcid":false,"given":"Caroline","family":"Foch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2362-0072","authenticated-orcid":false,"given":"Arthur","family":"Allignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0770-4743","authenticated-orcid":false,"given":"Ulrike","family":"Hostalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9657-9376","authenticated-orcid":false,"given":"Emmanuelle","family":"Boutmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0021-1401","authenticated-orcid":false,"given":"Thilo","family":"Hohenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,7,30]]},"reference":[{"key":"e_1_2_11_1_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.19.2560"},{"key":"e_1_2_11_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-307516"},{"key":"e_1_2_11_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000431740.32696.cc"},{"key":"e_1_2_11_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy339"},{"key":"e_1_2_11_5_2","unstructured":"The National Institute for Health and Care Excellence (NICE) Hypertension in adults: diagnosis and management 2019 2021 https:\/\/www.nice.org.uk\/guidance\/ng136."},{"key":"e_1_2_11_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/hjh.0000000000000447"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd002003.pub5"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2013.05.130048"},{"key":"e_1_2_11_9_2","unstructured":"Clinical practice research datalink (CPRD) 2020 https:\/\/www.cprd.com\/."},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv098"},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.7326\/m18-3079"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-014-0214-3"},{"key":"e_1_2_11_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4747"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3537"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1999.10474144"},{"key":"e_1_2_11_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.10.060"},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.21618"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2018.01.010"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002513"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/ijclp\/2022\/6124559.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ijclp\/2022\/6124559.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/2022\/6124559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:57:13Z","timestamp":1757581033000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2022\/6124559"}},"subtitle":[],"editor":[{"given":"Bing","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1155\/2022\/6124559"],"URL":"https:\/\/doi.org\/10.1155\/2022\/6124559","archive":["Portico"],"relation":{},"ISSN":["1368-5031","1742-1241"],"issn-type":[{"value":"1368-5031","type":"print"},{"value":"1742-1241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"2021-10-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"6124559"}}